Suchergebnisse - "O'Connor, Owen A"

PubPharm (287)

31

COMBINATION THERAPY OF LYMPHOMA

enthalten in: Europäisches Patentamt | 2020

von AMENGUAL JENNIFER EFFIE | LUE JENNIFER | O'CONNOR OWEN A

32

Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

enthalten in: Leukemia & lymphoma | 2020

von Sawas, A. | Ma, H. | Shustov, A. | +5

33

Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

enthalten in: British journal of haematology | 2020

von LaCasce, A. | Bociek, R. | Sawas, A. | +14

34

The anti-tumor activity of pralatrexate (PDX) correlates with the expression of RFC and DHFR mRNA in preclinical models of multiple myeloma

enthalten in: Oncotarget | 2020

von Kinahan, C. | Mangone, M. | Scotto, L. | +4

35

Survival benefit in patients with peripheral T-cell lymphomas after treatments with novel therapies and clinical trials

enthalten in: Hematological oncology | 2020

von Ma, H. | Cheng, B. | Falchi, L. | +4

36

CK1 Delta Is an mRNA Cap-Associated Protein That Drives Translation Initiation and Tumor Growth

enthalten in: bioRxiv.org | 2020

von Pal, I. | Grilo, A. | Berchowitz, L. | +12

37

Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma : a retrospective case series

enthalten in: Therapeutic advances in hematology | 2020

von Ma, H. | Cheng, B. | Montanari, F. | +5

38

The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management

enthalten in: CA: a cancer journal for clinicians | 2020

von Marchi, E. | O'Connor, O.

39

Three‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

enthalten in: British Journal of Haematology | 2020

von LaCasce, A. | Bociek, R. | Sawas, A. | +14

40

Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers

enthalten in: Genes, Chromosomes and Cancer | 2020

von Scotto, L. | Kinahan, C. | Casadei, B. | +9